These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33026641)

  • 1. Artificial Intelligence, Real-World Automation and the Safety of Medicines.
    Bate A; Hobbiger SF
    Drug Saf; 2021 Feb; 44(2):125-132. PubMed ID: 33026641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.
    Kassekert R; Grabowski N; Lorenz D; Schaffer C; Kempf D; Roy P; Kjoersvik O; Saldana G; ElShal S
    Drug Saf; 2022 May; 45(5):439-448. PubMed ID: 35579809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices.
    Huysentruyt K; Kjoersvik O; Dobracki P; Savage E; Mishalov E; Cherry M; Leonard E; Taylor R; Patel B; Abatemarco D
    Drug Saf; 2021 Mar; 44(3):261-272. PubMed ID: 33523400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
    Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
    Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities.
    Lewis DJ; McCallum JF
    Ther Innov Regul Sci; 2020 Jul; 54(4):888-899. PubMed ID: 32557311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why Are We Still Creating Individual Case Safety Reports?
    Streefland MB
    Clin Ther; 2018 Dec; 40(12):1973-1980. PubMed ID: 30420290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing.
    Schmider J; Kumar K; LaForest C; Swankoski B; Naim K; Caubel PM
    Clin Pharmacol Ther; 2019 Apr; 105(4):954-961. PubMed ID: 30303528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automation Opportunities in Pharmacovigilance: An Industry Survey.
    Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
    Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.
    Kompa B; Hakim JB; Palepu A; Kompa KG; Smith M; Bain PA; Woloszynek S; Painter JL; Bate A; Beam AL
    Drug Saf; 2022 May; 45(5):477-491. PubMed ID: 35579812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence and the Future of the Drug Safety Professional.
    Danysz K; Cicirello S; Mingle E; Assuncao B; Tetarenko N; Mockute R; Abatemarco D; Widdowson M; Desai S
    Drug Saf; 2019 Apr; 42(4):491-497. PubMed ID: 30343417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider.
    Hauben M; Hartford CG
    Clin Ther; 2021 Feb; 43(2):372-379. PubMed ID: 33478803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):115-129. PubMed ID: 36577617
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacovigilance in Crisis: Drug Safety at a Crossroads.
    Price J
    Clin Ther; 2018 May; 40(5):790-797. PubMed ID: 29605513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automation With Intelligence in Drug Research.
    Tu H; Lin Z; Lee K
    Clin Ther; 2019 Nov; 41(11):2436-2444. PubMed ID: 31582192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.
    Liang L; Hu J; Sun G; Hong N; Wu G; He Y; Li Y; Hao T; Liu L; Gong M
    Drug Saf; 2022 May; 45(5):511-519. PubMed ID: 35579814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automation, machine learning, and artificial intelligence in echocardiography: A brave new world.
    Gandhi S; Mosleh W; Shen J; Chow CM
    Echocardiography; 2018 Sep; 35(9):1402-1418. PubMed ID: 29974498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence and Machine Learning for Safe Medicines.
    Bate A; Luo Y
    Drug Saf; 2022 May; 45(5):403-405. PubMed ID: 35579805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance strategy: opportunities for cross-national learning.
    Fermont I
    Isr J Health Policy Res; 2019 Jun; 8(1):54. PubMed ID: 31217025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of medicines and vaccines - building next generation capability.
    Bate A; Stegmann JU
    Trends Pharmacol Sci; 2021 Dec; 42(12):1051-1063. PubMed ID: 34635346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.